These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21068648)

  • 1. Effect of cyamemazine on the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: a preliminary retrospective study.
    Lancelin F; Bourcier E; Le Masson V; Lemeille Y; Brovedani S; Paubel P; Piketty ML
    Ther Drug Monit; 2010 Dec; 32(6):757-61. PubMed ID: 21068648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.
    Jung SM; Kim KA; Cho HK; Jung IG; Park PW; Byun WT; Park JY
    Clin Pharmacol Ther; 2005 Nov; 78(5):520-8. PubMed ID: 16321618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age and gender on risperidone plasma concentrations.
    Aichhorn W; Weiss U; Marksteiner J; Kemmler G; Walch T; Zernig G; Stelzig-Schoeler R; Stuppaeck C; Geretsegger C
    J Psychopharmacol; 2005 Jul; 19(4):395-401. PubMed ID: 15982995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.
    Yasui-Furukori N; Mihara K; Takahata T; Suzuki A; Nakagami T; De Vries R; Tateishi T; Kondo T; Kaneko S
    Br J Clin Pharmacol; 2004 May; 57(5):569-75. PubMed ID: 15089809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response.
    Lostia AM; Mazzarini L; Pacchiarotti I; Lionetto L; De Rossi P; Sanna L; Sani G; Kotzalidis GD; Girardi P; Simmaco M; Tatarelli R
    Ther Drug Monit; 2009 Aug; 31(4):475-81. PubMed ID: 19531984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection.
    Aravagiri M; Marder SR; Wirshing D; Wirshing WC
    Pharmacopsychiatry; 1998 May; 31(3):102-9. PubMed ID: 9657237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia.
    Nagasaki T; Ohkubo T; Sugawara K; Yasui N; Furukori H; Kaneko S
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):595-601. PubMed ID: 10704125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CYP2D6 genotype on steady-state serum concentrations of risperidone and 9-hydroxyrisperidone in patients using long-acting injectable risperidone.
    Hendset M; Molden E; Refsum H; Hermann M
    J Clin Psychopharmacol; 2009 Dec; 29(6):537-41. PubMed ID: 19910717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone.
    Titier K; Déridet E; Moore N
    Toxicol Appl Pharmacol; 2002 Apr; 180(2):145-9. PubMed ID: 11969382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R; Shinkai K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2007 Jan; 40(1):9-13. PubMed ID: 17327954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders.
    Jones T; Van Breda K; Charles B; Dean AJ; McDermott BM; Norris R
    Biomed Chromatogr; 2009 Sep; 23(9):929-34. PubMed ID: 19353731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection.
    Locatelli I; Mrhar A; Grabnar I
    J Pharm Biomed Anal; 2009 Dec; 50(5):905-10. PubMed ID: 19589654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
    Bork JA; Rogers T; Wedlund PJ; de Leon J
    J Clin Psychiatry; 1999 Jul; 60(7):469-76. PubMed ID: 10453802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.
    Gunes A; Spina E; Dahl ML; Scordo MG
    Ther Drug Monit; 2008 Oct; 30(5):628-33. PubMed ID: 18708991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2011 Oct; 31(5):633-7. PubMed ID: 21869689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of venlafaxine on the pharmacokinetics of risperidone.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    J Clin Pharmacol; 1999 Mar; 39(3):297-309. PubMed ID: 10073330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia.
    Yasui-Furukori N; Mihara K; Kondo T; Kubota T; Iga T; Takarada Y; De Vries R; Kaneko S; Tateishi T
    J Clin Pharmacol; 2003 Feb; 43(2):122-7. PubMed ID: 12616663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of risperidone and 9-hydroxyrisperidone in plasma by high performance liquid chromatography].
    Xiao H; Yang J; Zhang S; Zhang X
    Se Pu; 1999 Jul; 17(4):395-6. PubMed ID: 12552862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry.
    Aravagiri M; Marder SR
    J Mass Spectrom; 2000 Jun; 35(6):718-24. PubMed ID: 10862124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.